Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2012
04/19/2012US20120094994 Functionalized amino acids and absorbable polymers therefrom
04/19/2012US20120094955 Method of dissolving an oxidized polysaccharide in an aqueous solution
04/19/2012US20120094940 Process of producing sugar composition comprising definite amount of target hexose and having sugar constitution different from that of starting sugar material and use of produced sugar composition
04/19/2012US20120094892 Prodrugs
04/19/2012US20120093926 Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid
04/19/2012US20120093925 Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
04/19/2012US20120093904 Composition comprising an anionic polymeric material and the salt of a saturated monocarboxylic acid having 6 to 22 carbon atoms
04/19/2012US20120093903 Powdery or granulated composition comprising a copolymer, a salt of a fatty monocarboxylic acid and a fatty monocarboxylic acid and/or a fatty alcohol
04/19/2012US20120093890 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
04/19/2012US20120093804 Concatamers for Immunemodulation
04/19/2012US20120093803 Means and methods of sterilization of biofunctional compositions
04/19/2012US20120093771 Method for preparing a hardened calcium sulfate dihydrate block and use thereof
04/19/2012US20120093762 Nucleic acid delivery compounds
04/19/2012US20120093759 Medical Devices, Wound Dressings, and Methods for Dressing Wounds
04/19/2012US20120093748 Topical personal care and pharmaceutical compositions and uses thereof
04/19/2012US20120093722 Synthetic diblock copolypeptide hydrogels for use in the central nervous system
04/19/2012US20120091605 Chewable Soft Capsule
04/19/2012CA2814696A1 Pharmaceutical formulation for histone deacetylase inhibitors
04/19/2012CA2814495A1 Clevidipine emulsion formulations containing antimicrobial agents
04/19/2012CA2814143A1 Methods and compositions for treating hemophilia b
04/19/2012CA2814097A1 Composition for treating cancer by the controlled release of an active substance
04/19/2012CA2814054A1 Formulation suitable for stabilizing proteins, which is free of mammalian excipients
04/19/2012CA2814031A1 Method for preparation of an excipient suitable for pharmaceutical use
04/19/2012CA2813781A1 Pharmaceutical compositions containing a dgat1 inhibitor
04/19/2012CA2812951A1 Engineered polypeptides having enhanced duration of action
04/19/2012CA2801332A1 New emd formulation comprising pga
04/18/2012EP2441779A1 Process for the preparation of sevelamer hydrochloride and formulation thereof
04/18/2012EP2441477A1 Wound-covering material
04/18/2012EP2441448A1 Gum resin as a carrier for topical application of pharmacologically active agents
04/18/2012EP2441440A1 Natural pharmacological aid for prevention of periodontal inflammatory disease
04/18/2012EP2441439A1 Pharmacological aid for prevention of incipient carious lesion and dentinal hypersensibility
04/18/2012EP2441437A1 Microneedle device
04/18/2012EP2440581A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
04/18/2012EP2440250A1 Targeted liposomes comprising n-containing bisphosphonates and uses thereof
04/18/2012EP2440249A2 Covalent conjugates comprising a protease inhibitor, a water-soluble, non-peptidic oligomer and a lipophilic moiety
04/18/2012EP2440248A1 Hydrophobins for dispersing active agents
04/18/2012EP2440247A1 Targeted nano-photomedicines for photodynamic therapy of cancer
04/18/2012EP2440239A1 Hemoglobin compositions
04/18/2012EP2440235A1 Glp-1 and fgf21 combinations for treatment of diabetes type 2
04/18/2012EP2440216A1 Use of a composition for the treatment of mucositis
04/18/2012EP2440213A1 Use of 1,25-dihydroxyvitamine d3 glycoside in lactating animals.
04/18/2012EP2440199A1 Semi-solid compositions and pharmaceutical products
04/18/2012EP2440192A2 Compositions and methods for delivery of materials
04/18/2012EP2440188A1 Solid compositions comprising 5-aminolevulinic acid
04/18/2012EP2440187A2 Amorphous varenicline tartrate co-precipitates
04/18/2012EP2440185A1 Topical drug delivery systems for ophthalmic use
04/18/2012EP2440183A1 Improved lipid formulation
04/18/2012EP2440180A2 Ipamorelin diacetate injection and infusion solutions
04/18/2012EP2440179A2 Chitosan oligosaccharide-based compositions
04/18/2012EP2074143B1 Altered antibodies
04/18/2012EP2066310B1 Emulsions comprising rubber arabicum
04/18/2012EP1895960B1 Transdermal delivery of cannabinoids
04/18/2012EP1861073B2 Process for the production of calcium compositions in a continuous fluid bed
04/18/2012EP1814524B1 Solid, oral, microparticulate dosage form which has been designed to prevent misuse
04/18/2012EP1709083B1 Adenocarcinoma specific antibody sam-6, and uses thereof
04/18/2012EP1641486B1 Stable, aqueous solution of human erythropoietin, not containing serum albumin
04/18/2012EP1534750B1 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
04/18/2012EP1499358B1 Ph-sensitive polymer
04/18/2012EP1338276B1 Adhesive preparation for external use
04/18/2012EP1284724B1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
04/18/2012CN1813699B Medicinal composition
04/18/2012CN1754536B Solution formulations of sirolimus and its analogs for cad treatment
04/18/2012CN102421827A Polymer conjugate of bioactive substance having hydroxy group
04/18/2012CN102421452A 多价佐剂展示 Multivalent adjuvant show
04/18/2012CN102421451A Bendamustine cyclopolysaccharide compositions
04/18/2012CN102421442A 阳离子羟乙基纤维素在经口摄取剂型中的用途以及代谢病症的预防和治疗 Cationic hydroxyethyl cellulose in the oral ingestion of the dosage form and the use of the prevention and treatment of metabolic disorders
04/18/2012CN102421426A 肠胃外给药的对乙酰氨基酚 Parenteral administration of acetaminophen
04/18/2012CN102421419A 用于持续药物传递的包含地聚合物粘合剂的组合物 For sustained drug delivery composition comprising a polymer binder to
04/18/2012CN102421418A 在药物递送中有用的中空金纳米球(HAuNSs)和装载HAuNSs的微球体 Be useful in drug delivery hollow gold nanospheres (HAuNSs) and loading of microspheres HAuNSs
04/18/2012CN102417733A 一种丝素蛋白纳米球的制备方法 One kind of silk fibroin nanoparticles preparation method
04/18/2012CN102417695A 一种木糖醇基弹性体复合材料及其制备方法 Xylitol-based elastomer composite material and its preparation method
04/18/2012CN102417569A 一种聚胺型两亲嵌段聚电解质 One polyamine-type amphiphilic block polyelectrolyte
04/18/2012CN102417551A 琥珀酰化壳聚糖衍生物的制备方法及其应用 Preparation succinylated chitosan derivative and its application
04/18/2012CN102417540A Polyethylene glycol-modified integrin blocking agent HM-3 and application thereof
04/18/2012CN102417208A 介孔磁性四氧化三铁、制备方法和应用 Mesoporous magnetic iron oxide, preparation and application
04/18/2012CN102416181A 生物降解高分子键合光活性Pt(IV)抗癌药胶束及制备方法 (IV) anti-cancer drug micelles and preparation of biodegradable polymer-bonded optical activity of the Pt
04/18/2012CN102416180A 一种功能集成药物载体及其制备方法 A feature integrated pharmaceutical carrier and its preparation method
04/18/2012CN102416178A Water-soluble non-aggregated alkoxy-substituted phthalocyanine-silica nanometer particle
04/18/2012CN102416176A Stabile isotonic lyophilized protein formulation
04/18/2012CN102416171A 高纯度凝血酶原复合物制品干热病毒灭活过程中的保护剂 High purity prothrombin complex products dry heat viral inactivation process protection agents
04/18/2012CN102416163A 一种含有植物血球凝集素或植物血球凝集素亚型的组合物 Containing phytohemagglutinin or phytohemagglutinin subtype composition
04/18/2012CN102416162A 一种经口腔粘膜吸收的还原型谷胱甘肽药物 One kind of oral mucosal absorption of glutathione drug
04/18/2012CN102416133A 盐益智仁配方颗粒及其制备方法 Salt particles Yizhiren recipe and preparation method
04/18/2012CN102416130A 一种治疗上呼吸道感染的中药滴丸及其制备方法 On a traditional Chinese medicine treatment of respiratory tract infections dropping pill and its preparation method
04/18/2012CN102416081A Process method for softening ointment layer of compound arisaema analgesic ointment
04/18/2012CN102416074A 一种戒烟的外敷药品贴 One kind of topical medications to quit smoking stickers
04/18/2012CN102416072A 一种油茶皂苷控释片及其制备方法 One kind sasanquasaponin GITS its preparation method
04/18/2012CN102416064A 治疗已破溃冻疮的药物 Drug treatment has ulceration of frostbite
04/18/2012CN102416061A 一种复方水包油型白术油纳米乳组合物及其制备方法 A COMPOUND oil-in-water nanoemulsion Baizhu oil composition and its preparation method
04/18/2012CN102416056A 一种降血脂复方纳米乳口服液及其制备方法 One kind of oral lipid nanoemulsion compound and its preparation method
04/18/2012CN102416054A Composition for treating onychomycosis and tinea manus and pedis
04/18/2012CN102416041A 一种抗菌消炎中药组合物及制备方法 An antibacterial anti-inflammatory medicine composition and preparation methods
04/18/2012CN102416033A 外用膏药及其制作方法 Topical plaster and manufacturing method thereof
04/18/2012CN102416024A 一种噬菌体口服微球制剂及其制备方法 An oral microsphere formulation and preparation method bacteriophage
04/18/2012CN102416008A 一种可缓慢释放抗肿瘤适体药物的微囊及其制备工艺 Microcapsules and preparation process for a slow release of anti-tumor drugs aptamer
04/18/2012CN102416007A 一种盐酸二甲双胍肠溶胶囊 One kind of metformin hydrochloride enteric-coated capsules
04/18/2012CN102416006A 一种羟苯磺酸钙胶囊及其制备方法 One kind of calcium dobesilate capsule and its preparation method
04/18/2012CN102416004A 格列美脲片及其制备方法 Glimepiride tablets and its preparation method
04/18/2012CN102416003A 一种制备恩替卡韦片剂的方法 A process for preparing entecavir tablets method
04/18/2012CN102416002A 前体凝胶型氟化物咀嚼片的组合物 Composition precursor gel fluoride chewable